Europe — EMA
Oxlumo (Lumasiran)
Lumasiran, the active ingredient in Oxlumo, is a RNA‑RNA therapeutic presented as a solution for subcutaneous injection use. It treats primary hyperoxaluria type 1 (PH1) by reducing hepatic oxalate production in…
Request sourcing
What is Lumasiran?
Lumasiran, the active ingredient in Oxlumo, is a RNA‑RNA therapeutic presented as a solution for subcutaneous injection use. It treats primary hyperoxaluria type 1 (PH1) by reducing hepatic oxalate production in patients with a confirmed genetic diagnosis of PH1. GNH USA supplies Oxlumo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
GNH USA supplies Oxlumo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies through its global network through the world wide ... (???)
What is Lumasiran used for?
Oxlumo ... .... ... ... ..........
